Tert-butyl (1S,5R)-6-[4-(fluorosulfonylmethyl)-2-oxopyrrolidin-1-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate
C15H23FN2O5S — CID 168674611
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl (1S,5R)-6-[4-(fluorosulfonylmethyl)-2-oxopyrrolidin-1-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate
Tert-butyl (1S,5R)-6-[4-(fluorosulfonylmethyl)-2-oxopyrrolidin-1-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate (PubChem CID 168674611) has the molecular formula C15H23FN2O5S and a molecular weight of 362.42 g/mol. Its IUPAC name is tert-butyl (1S,5R)-6-[4-(fluorosulfonylmethyl)-2-oxopyrrolidin-1-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl (1S,5R)-6-[4-(fluorosulfonylmethyl)-2-oxopyrrolidin-1-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate |
|---|---|
| PubChem CID | 168674611 |
| Molecular Formula | C15H23FN2O5S |
| Molecular Weight | 362.42 g/mol |
| Exact Mass | 362.13 |
| IUPAC Name | tert-butyl (1S,5R)-6-[4-(fluorosulfonylmethyl)-2-oxopyrrolidin-1-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1C[C@@H]2C(N3CC(CS(=O)(=O)F)CC3=O)[C@@H]2C1 |
| InChI | InChI=1S/C15H23FN2O5S/c1-15(2,3)23-14(20)17-6-10-11(7-17)13(10)18-5-9(4-12(18)19)8-24(16,21)22/h9-11,13H,4-8H2,1-3H3/t9?,10-,11+,13? |
| InChIKey | PBFHTQQNBMFNJN-VOZVASTJSA-N |
| XLogP | 1.00 |
| TPSA | 83.99 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 362.42 |
| LogP ≤ 5 | 1.00 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168674611 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.